In the neutropenic patient, the use of colony stimulating factors (granulocyte-colony stimulating factor (G-CSF) or granulocyte macrophage-colony stimulating factor (GM-CSF)) are recommended in attempts to minimize the duration of neutropenia. This evidence concerns the gene CSF2 and neutropenia.